BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1899625)

  • 1. Immune modifying effects of misoprostol and natural prostaglandins.
    Iyengar S; Contreras PC; Mick SJ; Bremer ME; McKearn JP
    Br J Rheumatol; 1991; 30 Suppl 2():71-4. PubMed ID: 1899625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of triple-therapy immunosuppression and prostaglandin analogues enisoprost and misoprostol.
    Hibbins M; Chapman JR
    Transplant Proc; 1992 Feb; 24(1):224-6. PubMed ID: 1539257
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive effect of misoprostol: a new synthetic prostaglandin E1 analogue.
    Wiederkehr JC; Dumble L; Pollak R; Moran M
    Aust N Z J Surg; 1990 Feb; 60(2):121-4. PubMed ID: 2109591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of candidates for adjunctive 'gastroprotective' prostaglandins.
    Adelizzi RA
    J Am Osteopath Assoc; 1990 Jul; 90(7):598-601. PubMed ID: 2115860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of misoprostol on gastric acid secretion in vitro. Qualitative differences from natural prostaglandins.
    Bertaccini G; Adami M; Coruzzi G
    Dig Dis Sci; 1988 Oct; 33(10):1265-8. PubMed ID: 3139378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro comparison of the immunosuppressive potential of synthetic prostaglandin analogues.
    Redgrave NG; Dumble LJ; Pollak R; Bowes LG; Ruwart MJ; Clunie GJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):346-7. PubMed ID: 1824986
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of a prostaglandin E1 analogue in the prevention of acute graft rejection by cyclosporine.
    N Engl J Med; 1990 Sep; 323(12):831-3. PubMed ID: 2118233
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandins in gastroenterology. Focus on misoprostol. Proceedings of an international symposium. Algarve, Portugal, September 13-14, 1984.
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):1S-205S. PubMed ID: 3932040
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential drug interactions with misoprostol: effects on the pharmacokinetics of antipyrine and propranolol.
    Bennett PN; Fenn GC; Notarianni LJ
    Postgrad Med J; 1988; 64 Suppl 1():21-4. PubMed ID: 3138681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB; Mahachai V
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of E series prostaglandins on blastogenic responses in vitro and graft vs. host responses in vivo.
    Duffie GP; Romanelli RR; Ellis NK; Young MR; Wepsic HT
    Immunopharmacol Immunotoxicol; 1988; 10(4):597-615. PubMed ID: 3246542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-type prostaglandin binding sites in isolated canine parietal cells: elucidation with (3H) misoprostol free acid.
    Tsai BS; Kessler LK; Schoenhard G; Collins PW; Bauer RF
    Z Gastroenterol; 1987 Apr; 25(4):201-6. PubMed ID: 2884786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in defining the role of misoprostol in rheumatology.
    Nicholson PA
    J Rheumatol Suppl; 1990 Feb; 20():50-3. PubMed ID: 2109076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin-stimulated recovery of the human duodenal epithelium: effects of misoprostol on ethanol damage.
    Foschi D; Marazzi M; Toti GL; Radaelli E; Ferrante F; Vaiani G; Galeone M; Trabucchi E
    Am J Gastroenterol; 1990 Nov; 85(11):1498-502. PubMed ID: 2122722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of some natural and synthetic prostaglandins (PGs) on gastric secretion "in vitro".
    Adami M; Bertaccini G
    Pharmacol Res Commun; 1988 Jul; 20(7):623-4. PubMed ID: 3140254
    [No Abstract]   [Full Text] [Related]  

  • 17. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE
    Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroimmunomodulation of the immune response by the endocrine system: effect of luteinizing hormone (LH) on the proliferative response of lymphocytes].
    Rouabhia M; Deschaux PA; Othmane O
    Jpn J Med Sci Biol; 1987 Aug; 40(4):147-51. PubMed ID: 3452673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
    Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
    J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins in the upper gastrointestinal tract. Focus on misoprostol. Proceedings of the second international symposium. New York City, May 9-10, 1985.
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):1S-150S. PubMed ID: 3080278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.